Workflow Services, a US-based platform to enable pharmacist-led clinical services, announced on Tuesday the successful completion of a one-year pilot and a nationwide expansion of its Colorectal Cancer Screening Education Program.
The aim of this initiative is to educate patients about the significance of colorectal cancer screening in the pharmacy setting. The program is intended to bridge the gap in preventive care because of the community pharmacy's unique position as many Americans' most accessible, trusted and frequently visited healthcare provider. In the pilot, 92% of the participating pharmacists reported increased proficiency in their ability to educate patients about the effect of colorectal cancer screening.
Following the pilot program's success, pharmacies across the country will now be able to use the Workflow Services platform to combine colorectal cancer screening education into their patient encounters.
Kevin Houlihan, Workflow Services president and CEO, said: "The data we collected in the pilot shows that we are unlocking a new, impactful healthcare channel. Access is one of the major challenges currently confronting the American healthcare system. And we've seen that by providing pharmacists with the right tools and guardrails in a platform like Workflow Services, we can make a real difference in closing care gaps and driving health outcomes."
Oncoinvent reports positive 18-month Phase 1 data for Radspherin in ovarian cancer trial
argenx receives positive CHMP opinion for VYVGART subcutaneous injection in CIDP treatment
Innovent's limertinib receives Chinese regulatory approval for first-line treatment of lung cancer
Johnson & Johnson reports TAR-200 monotherapy study data in bladder cancer
InnoCare receives NMPA approval for orelabrutinib as first-line treatment for CLL/SLL in China
RaySearch Laboratories announces order from Odense University Hospital for RayStation
Primo Biotechnology's Taoyuan facility granted PIC/S GMP Certification
Renibus Therapeutics completes RBT-1 Phase 3 clinical trial enrolment
Guardant Health and Pfizer enter global collaboration to advance cancer therapy development
Adcendo to present clinical stage ADC data at 2025 AACR Annual Meeting
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)